Related Experiment Video
Updated: May 18, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
[Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease]
Insights
Left ventricular hypertrophy (LVH) affects over a third of chronic kidney disease (CKD) patients, linked to both traditional and kidney-specific risk factors. Early detection and management of CKD are crucial for preventing cardiac complications.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Context:
- Chronic kidney disease (CKD) is a growing global health concern.
- CKD is associated with a significantly increased risk of cardiovascular complications.
- Left ventricular hypertrophy (LVH) is a common cardiac manifestation in CKD patients.
Purpose:
- To determine the prevalence of LVH in patients with stages II-IV CKD.
- To identify conventional and renal-specific risk factors associated with LVH development in CKD patients.
- To analyze the different geometric models of LVH in this population.
Summary:
- LVH was observed in 37.3% of 83 CKD patients (stages II-IV).
- LVH development was associated with age, arterial hypertension, hypercholesterolemia, reduced GFR, anemia, and hyperphosphatemia.
- Eccentric LVH was more common with renal factors, while concentric LVH correlated with higher systolic blood pressure.
Impact:
- Highlights the high prevalence of LVH in early to moderate CKD.
- Underscores the importance of managing both traditional and renal-related risk factors for cardiovascular health in CKD.
- Informs clinical practice regarding cardiac risk stratification and management in CKD patients.
Aim:
To evaluate frequency and risk factors of development of left ventricular hypertrophy (LVH) of the heart in patients with chronic kidney disease (CKD) of stage II-IV.
Material And Methods:
The trial enrolled 83 patients (42 - 51% males, 41 - 49% females, mean age 46.7 years) with stage II-IV CKD of non-diabetic origin. Glomerular filtration rate (GFR) estimated according to Cockroft-Goult formula was 37,7 ml/min (95% confidence interval from 33,9 do 41,4). Chronic renal failure duration averaged 2,7 years (95 % CI from 2.0 to 3.3). Arterial hypertension (AH) was diagnosed in 96% patients, hereditary predisposition to cardiovascular diseases - in 54%, obesity - in 60%. lipid disbolism - in 66%, anemia - in 34 % and hyperphosphatemia - in 45%; 40% patients smoked. Echocardiography was performed in all the patients.
Results:
LVH was detected in 31 (37.3%) of 83 patients. With progression of renal failure, frequency of registration of LVH increased LVH onset was associated with conventional (age, AH, high level of total cholesterol) and renal (lowering of GFR, anemia, hyperphosphatemia) factors. Concentric remodeling, concentric LVH, eccentric LVH were detected in 31.3, 19.3 and 18.1% patients, respectively. Eccentric LVH developed more frequently under the influence of factors associated with renal failure (GFR, anemia, hyperphosphatemia, hypocalcemia). Concentric LVH was characterized with the highest systolic blood pressure.
Conclusion:
Patients with renal dysfunction develop LVH of different geometric model associated with both conventional and renal risk factors even at early stages of CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...